Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
Acumen Pharmaceuticals (ABOS) Financial Statements
45 Followers
Acumen Pharmaceuticals Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | $ -1.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | $ -1.00K | - | - | - |
| EBIT | $ -13.14M | $ -14.26M | $ -11.37M | $ -10.41M | $ -9.21M |
| EBITDA | $ -13.42M | $ -14.30M | $ -11.33M | $ -10.37M | $ -9.17M |
| Net Income Common Stockholders | $ -11.31M | $ -12.87M | $ -10.71M | $ -10.15M | $ -9.13M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 140.41M | $ 177.60M | $ 200.19M | $ 189.91M | $ 189.09M |
| Total Assets | $ 187.71M | $ 196.59M | $ 203.26M | $ 211.68M | $ 220.09M |
| Total Debt | $ 67.00K | $ 105.00K | $ 133.00K | $ 167.00K | $ 201.00K |
| Net Debt | $ -140.34M | $ -177.50M | $ -200.06M | $ -189.74M | $ -188.89M |
| Total Liabilities | $ 8.26M | $ 7.81M | $ 6.61M | $ 5.16M | $ 4.00M |
| Stockholders Equity | $ 179.64M | $ 188.78M | $ 196.65M | $ 206.52M | $ 216.09M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -10.18M | $ -11.24M | $ -9.26M | $ -6.50M | $ -8.31M |
| Operating Cash Flow | $ -10.18M | $ -11.20M | $ -9.18M | $ -6.47M | $ -8.30M |
| Investing Cash Flow | $ -41.93M | $ -20.42M | $ 55.92M | $ 8.79M | $ -5.10M |
| Financing Cash Flow | - | $ 4.18M | $ -263.00K | - | - |